Drugs / CBD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05514899 | Sep 2023 → Oct 2027 expected | HIV infectious disease | University of California, San Diego | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05514899 ↗ |
| Route | Oral | “14 days each of oral THC and CBD” NCT05514899 ↗ |